Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect01:26

Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect

The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterizing how community pharmacy teams engage with social drivers of health (SDOH) during routine workflow: A report from the medication safety research network of Indiana (Rx-SafeNet).

Journal of the American Pharmacists Association : JAPhA·2026
Same author

Social Media Use, Personality Characteristics, and Social Isolation among Young Adults in the United States.

Personality and individual differences·2026
Same author

Use of Multiple Social Media Platforms and Symptoms of Depression and Anxiety: A Nationally-Representative Study among U.S. Young Adults.

Computers in human behavior·2026
Same author

Closeness of Social Media Contacts and Loneliness Among US Adults: A Nationally Representative Study.

Public health reports (Washington, D.C. : 1974)·2026
Same author

Developing investigator guidance for pharmacy compensation for research participation: A report from the medication safety research network of Indiana (Rx-SafeNet).

Journal of the American Pharmacists Association : JAPhA·2026
Same author

Enhancing community pharmacists' role in research: Insights and challenges in recruiting through pharmacy practice-based research networks.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Do medication adherence trajectories predict clinical endpoints in a cohort with HIV and chronic comorbidities?

Research in social & administrative pharmacy : RSAP·2026
Same journal

Mapping global evidence on pharmacy-based colorectal cancer screening initiatives in community settings: A scoping review.

Research in social & administrative pharmacy : RSAP·2026
Same journal

Effectiveness of a pharmacist-led protocol to manage cystitis in women, in France: the PharmaCyst' open-label, multicenter, randomized, controlled, cluster study.

Research in social & administrative pharmacy : RSAP·2026
Same journal

Factors associated with successful integration of pharmacists into residential aged care teams: A qualitative study.

Research in social & administrative pharmacy : RSAP·2026
Same journal

Automating the roter interaction analysis system for medication counseling: A transformer-based deep learning approach with generative AI-augmented data.

Research in social & administrative pharmacy : RSAP·2026
Same journal

Effect of a collaborative intervention by pharmacists and dentists on smoking cessation.

Research in social & administrative pharmacy : RSAP·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
14:32

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

Exploring successful community pharmacist-physician collaborative working relationships using mixed methods.

Margie E Snyder1, Alan J Zillich, Brian A Primack

  • 1Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Purdue University, W7555 Myers Building, 1001 W. 10th Street, Indianapolis, IN 46202, USA.

Research in Social & Administrative Pharmacy : RSAP
|November 30, 2010
PubMed
Summary
This summary is machine-generated.

Successful collaborative working relationships (CWRs) between pharmacists and physicians are built on open communication and consistent, high-quality patient care contributions. Pharmacists initiating contact and demonstrating commitment are key to developing trust and defining professional roles.

Related Experiment Videos

Last Updated: Jun 6, 2026

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
14:32

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

Area of Science:

  • Pharmacy practice
  • Interprofessional collaboration
  • Healthcare professional relationships

Background:

  • Community pharmacists and physicians can improve patient care through collaborative working relationships (CWRs).
  • Pharmacists face challenges in establishing these crucial professional relationships.
  • Understanding pharmacist-physician exchanges is vital for developing effective collaboration models.

Purpose of the Study:

  • To describe professional exchanges between community pharmacists and physicians in successful CWRs.
  • To utilize a published conceptual model and tool to quantify collaboration levels.

Main Methods:

  • Experts identified community pharmacists in CWRs with physicians nationally.
  • Five pharmacist-physician pairs underwent semistructured interviews.
  • Four pairs completed the Pharmacist-Physician Collaborative Index (PPCI) for quantitative and qualitative data on relationship initiation, trustworthiness, and role specification.

Main Results:

  • Physicians scored higher on relationship initiation and role specification, while both scored similarly on trustworthiness.
  • Pharmacists initiating relationships through face-to-face visits fostered open communication.
  • Physicians recognized pharmacists' commitment to patient care, built on consistent, outcome-improving contributions and clear role discussions.

Conclusions:

  • Findings support existing models of CWRs, highlighting the pharmacist's role in initiating relationships.
  • Effective communication in early stages and high-quality pharmacist contributions are crucial for developing trust.
  • Successful collaboration requires acknowledging professional norms while emphasizing shared patient care goals.